The extent and correlates of community‐based pharmaceutical opioid utilisation in Australia

There has been concern regarding the increasing use of opioids and related harm. We present data on opioid utilisation across Australia and consider sociodemographic factors that may affect utilisation rates.

[1]  R. Bruno,et al.  Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids. , 2015, Drug and alcohol review.

[2]  R. Bruno,et al.  The characteristics of a cohort who tamper with prescribed and diverted opioid medications. , 2015, Journal of substance abuse treatment.

[3]  S. Nielsen,et al.  Trends and characteristics of accidental and intentional codeine overdose deaths in Australia , 2015, The Medical journal of Australia.

[4]  W. Hall,et al.  Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) Cohort. , 2015, Pain medicine.

[5]  T. Gomes,et al.  Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study , 2015, PloS one.

[6]  J. Henningfield,et al.  A meta-analysis based on diffuse definitions and mixed quality literature is not a good fundament for decisions on treatment of chronic pain patients. , 2015, Pain.

[7]  J. Najman,et al.  Opioid analgesic prescribing in Australia: a focus on gender and age , 2015, Pharmacoepidemiology and drug safety.

[8]  S. Nielsen,et al.  Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case series. , 2015, Drug and alcohol review.

[9]  R. Bruno,et al.  Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011. , 2015, Drug and alcohol dependence.

[10]  K. Vowles,et al.  Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis , 2015, Pain.

[11]  Chris Ringwalt,et al.  The Effects of North Carolina’s Prescription Drug Monitoring Program on the Prescribing Behaviors of the State’s Providers , 2015, The Journal of Primary Prevention.

[12]  R. Chou,et al.  The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop , 2015, Annals of Internal Medicine.

[13]  M. N. Lutfiyya,et al.  Opioid prescribing patterns for non-malignant chronic pain for rural versus non-rural US adults: a population-based study using 2010 NAMCS data , 2014, BMC Health Services Research.

[14]  S. Pearson,et al.  An overview of the patterns of prescription opioid use, costs and related harms in Australia. , 2014, British journal of clinical pharmacology.

[15]  Annesa Flentje,et al.  Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals. , 2014, Drug and alcohol dependence.

[16]  D. Wijeysundera,et al.  Rates and risk factors for prolonged opioid use after major surgery: population based cohort study , 2014, BMJ : British Medical Journal.

[17]  S. Galea,et al.  Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. , 2014, American journal of public health.

[18]  F. Blyth,et al.  Adverse Selection? A Multi-Dimensional Profile of People Dispensed Opioid Analgesics for Persistent Non-Cancer Pain , 2013, PloS one.

[19]  W. Hall,et al.  Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia. , 2013, Drug and alcohol review.

[20]  L. Degenhardt,et al.  Trends in fentanyl prescriptions and fentanyl-related mortality in Australia. , 2013, Drug and alcohol review.

[21]  J. Rehm,et al.  High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005 – 2009 , 2013, Pharmacoepidemiology and drug safety.

[22]  L. Amato,et al.  Development of dependence following treatment with opioid analgesics for pain relief: a systematic review. , 2013, Addiction.

[23]  J. Najman,et al.  Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia , 2013, Australian and New Zealand journal of public health.

[24]  M. Ho,et al.  Trends in Hepatic Injury Associated with Unintentional Overdose of Paracetamol (Acetaminophen) in Products with and without Opioid , 2012, Drug Safety.

[25]  G. Bond,et al.  Erratum to Trends in hepatic injury associated with unintentional overdose of paracetamol (acetaminophen) in products with and without opioid: an analysis using the National Poison Data System of the American Association of Poison Control Centers, 2000–7 , 2012, Drug Safety.

[26]  J. Rehm,et al.  Correlations between population levels of prescription opioid use and prescription-opioid-related substance use treatment admissions in the USA and Canada since 2001. , 2012, Public health.

[27]  S. Nielsen,et al.  OTC codeine: Examining the evidence for and against , 2012 .

[28]  Wayne Hall,et al.  Extent of illicit drug use and dependence, and their contribution to the global burden of disease , 2012, The Lancet.

[29]  Yihua Xu,et al.  Opioid-Paracetamol Prescription Patterns and Liver Dysfunction , 2011, Drug safety.

[30]  Raimondo Bruno,et al.  Prescription of opioid analgesics and related harms in Australia , 2011, The Medical journal of Australia.

[31]  K. Hamunen,et al.  Choosing the unit of measurement counts: The use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses , 2011, Palliative medicine.

[32]  Joan Ozanne-Smith,et al.  Increasing deaths involving oxycodone, Victoria, Australia, 2000–09 , 2010, Injury Prevention.

[33]  M. Sullivan.  Who gets high-dose opioid therapy for chronic non-cancer pain? , 2010, PAIN®.

[34]  S. Nielsen,et al.  Serious morbidity associated with misuse of over‐the‐counter codeine–ibuprofen analgesics: a series of 27 cases , 2010, The Medical journal of Australia.

[35]  H. Sørensen,et al.  The Nordic countries as a cohort for pharmacoepidemiological research. , 2010, Basic & clinical pharmacology & toxicology.

[36]  S. Tregear,et al.  Long-term opioid management for chronic noncancer pain. , 2010, The Cochrane database of systematic reviews.

[37]  P. Haber,et al.  Examination of opioid prescribing in Australia from 1992 to 2007 , 2009, Internal medicine journal.

[38]  H. McQuay,et al.  Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults. , 2009, The Cochrane database of systematic reviews.

[39]  C. Flowers,et al.  Prescription Opioid Usage and Abuse Relationships: An Evaluation of State Prescription Drug Monitoring Program Efficacy , 2009, Substance abuse : research and treatment.

[40]  J. Havens,et al.  Differences in Prevalence of Prescription Opiate Misuse Among Rural and Urban Probationers , 2007, The American journal of drug and alcohol abuse.

[41]  Raimondo Bruno,et al.  Australian Drug Trends 2004: Findings from the Illicit Drug Reporting System (IDRS) , 2006 .

[42]  Yongli Xi,et al.  Increasing deaths from opioid analgesics in the United States , 2006, Pharmacoepidemiology and drug safety.

[43]  K. Dolan,et al.  Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users. , 2006, The Australian journal of rural health.

[44]  C. Schmidt.  Experts worry about chilling effect of federal regulations on treating pain. , 2005, Journal of the National Cancer Institute.

[45]  Y. Daali,et al.  Codeine intoxication associated with ultrarapid CYP2D6 metabolism. , 2004, The New England journal of medicine.

[46]  F. Blyth,et al.  Chronic pain in Australia: a prevalence study , 2001, Pain.

[47]  John Lynch,et al.  Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study , 1995, Pain.

[48]  S. Grond,et al.  Validation of World Health Organization Guidelines for Pain Relief in Head and Neck Cancer , 1993 .

[49]  K. Ribisl,et al.  OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality , 2016 .

[50]  R. Moore,et al.  Single dose oral ibuprofen plus codeine for acute postoperative pain in adults. , 2015, The Cochrane database of systematic reviews.

[51]  S. Nielsen,et al.  Comparing opioids: A guide to estimating oral morphine equivalents (OME) in research , 2014 .

[52]  Leonard J. Paulozzi,et al.  Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. , 2011, MMWR. Morbidity and mortality weekly report.